Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.
Athletes have always sought to outperform their competitors and regrettably some have resorted to misuse of drugs or doping to achieve this. Stimulants were taken by the first Olympic athletes to be disqualified in 1972. Although undetectable until 1975, from the 1950s androgenic anabolic steroids were administered for increased strength and power followed in the 1990s by erythropoietin for enhanced endurance. Both are highly effective doping agents. As analytical science validated improved techniques to identify these drugs, Olympic athletes, including many medallists were caught and disqualified. When the International Olympic Committee (IOC) prohibited beta blockers (beneficial in shooting), diuretics (assist weight classified athletes) and glucocorticosteroids, some athletes with genuine medical conditions were denied legitimate medical therapy. To overcome this, in 1992 the IOC introduced a system known now as Therapeutic Use Exemption (TUE). This paper discusses Olympic athletes who have been known to dope at past Games and some medical indications and pitfalls in the TUE process.
School Sports Science, Exercise and Health, Faculty of Life Sciences, University of Western Australia, Australia. ken.fitch@uwa.edu.au
Ken
K
Fitch
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D045930:Anabolic Agents / Q000494:pharmacology; D056352:Athletes / Q000523:psychology*; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D003163:Competitive Behavior; D004232:Diuretics / Q000494:pharmacology; D004300:Doping in Sports / Q000331:legislation & jurisprudence / Q000379:methods / Q000517:prevention & control; D004921:Erythropoietin / Q000494:pharmacology; D006801:Humans; D010807:Physical Endurance / Q000187:drug effects*; D055553:Prescription Drugs / Q000494:pharmacology*; D011597:Psychomotor Performance / Q000187:drug effects*; D013177:Sports / Q000331:legislation & jurisprudence / Q000523:psychology; D015813:Substance Abuse Detection / Q000331:legislation & jurisprudence / Q000379:methods
D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists; D045930:Anabolic Agents; D000697:Central Nervous System Stimulants; D006063:Chorionic Gonadotropin; D004232:Diuretics; D055553:Prescription Drugs; D004921:Erythropoietin